578 CD8-targeted IL-2 drives potent anti-tumor efficacy and promotes action of tumor specific vaccines

Benzer Materyaller

• 578 CD8-targeted IL-2 drives potent anti-tumor efficacy and promotes action of tumor specific vaccines
  Yazar:: Hussein Sultan, ve diğerleri
  Baskı/Yayın Bilgisi: (2021-11-01)
• 1048 AB821 is a CD8+ T cell selective IL-21 with enhanced bioavailability that reduces CD8+ T cell exhaustion to induce potent antitumor activity
  Yazar:: Ivana Djuretic, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-11-01)
• Metabolic modulation of CD8⁺ T cells by metformin: A promising adjuvant strategy for CD8⁺ T Cell-Based Immunotherapies
  Yazar:: Quynh Chau Ton Nu, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-12-01)
• In vitro IL-15-activated human naïve CD8+ T cells down-modulate the CD8β chain and become CD8αα T cells
  Yazar:: André J. Esgalhado, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-06-01)
• Determination of CD4, CD8, and IL-8 levels in serum and bronchoalveolar lavage fluid of anthracosis patients
  Yazar:: Arda Kiani, ve diğerleri
  Baskı/Yayın Bilgisi: (2018-01-01)